Edwards Lifesciences Corp — Director's Dealing 2021

Aug 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-08-10

Reporting Person: Wood Larry L (CVP, TAVR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	M	7830.0000	$35.1967	Acquired	379963.5508	Direct
2021-08-10	Common Stock	S	7830.0000	$114.1351	Disposed	372133.5508	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-10	Employee Stock Option (Right to Acquire)	$35.1967	M	7830.0000	Disposed	2023-05-11	Common Stock (7830.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	495.9158	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $113.7250 to $114.4400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F3: Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.